Compare Mahindra Manulife Innovation Opportunities Fund vs Bandhan Innovation Fund
Mahindra Manulife Innovation Opportunities Fund
EquityThematic-Innovation
Bandhan Innovation Fund
EquityThematic-Innovation
Risk
Very High
Very High
Rating
-
-
Min SIP Amount
₹500
₹100
Expense Ratio
2.56
2.26
NAV
₹10.23
₹15.16
Fund Started
09 Jan 2026
10 Apr 2024
Fund Size
₹256.96 Cr
₹3085.41 Cr
Exit Load
Exit load of 0.5%, if redeemed within 3 months.
Exit load of 0.50%, if redeemed within 30 days.
1 Year
-
7.71%
3 Year
-
-
5 Year
-
-
Equity
97.53%
98.54%
Cash
2.47%
1.45%
Top 10 Holdings
Name | Assets |
|---|---|
Eternal Ltd. | 3.79% |
Bajaj Finance Ltd. | 2.73% |
One 97 Communications Ltd. | 2.64% |
ICICI Bank Ltd. | 2.61% |
Aditya Birla Capital Ltd. | 2.60% |
Acutaas Chemicals Ltd. | 2.59% |
Torrent Pharmaceuticals Ltd. | 2.57% |
Reliance Industries Ltd. | 2.53% |
Belrise Industries Ltd. | 2.44% |
Karur Vysya Bank Ltd. | 2.32% |
Name | Assets |
|---|---|
Eternal Ltd. | 5.67% |
One 97 Communications Ltd. | 4.80% |
Bajaj Finserv Ltd. | 3.46% |
ICICI Bank Ltd. | 2.90% |
Meesho Ltd. | 2.80% |
Sterlite Technologies Ltd. | 2.44% |
Astrazeneca Pharma India Ltd. | 2.41% |
Coforge Ltd. | 2.16% |
Mahindra & Mahindra Ltd. | 2.02% |
Reliance Industries Ltd. | 1.98% |
Name
-
-
Start Date
-
-
Description
The Scheme shall seek to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies following innovation theme.
The Scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies following innovation theme.
Launch Date
09 Jan 2026
10 Apr 2024
